Jerome J Jendrisak

USPTO Granted Patents = 42 (Patent Applications = 6)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 21 (Patent Applications = 21)

Average Co-Inventor Count = 3.3

ph-index = 16

Forward Citations = 1,282(Granted Patents)

Location History:

Madison, WI (US) (1988 - 2023)
Middleton, WI (US) (2014 - 2024)

Company Filing History:

20 out of 28

Epicentre Technologies Corporation

University of Pennsylvania

University of Texas System

patents

7. 3 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1988-2025

Loading Chart...

42 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12371687 - Transposon end compositions and methods for modifying nucleic acids (2025-07-29),

2. 12180468 - Transposase compositions for reduction of insertion bias (2024-12-31),

3. 12059479 - Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect (2024-08-13),

4. 11739300 - RNA preparations comprising purified modified RNA for reprogramming cells (2023-08-29),

5. 11135314 - Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect (2021-10-05),

6. 11118175 - Transposon end compositions and methods for modifying nucleic acids (2021-09-14),

7. 11028370 - RNA preparations comprising purified modified RNA for reprogramming cells (2021-06-08),

8. 10815478 - Method of sequential tagmentation with transposase compositions for reduction of insertion bias (2020-10-27),

9. 10201620 - Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect (2019-02-12),

10. 10184122 - Transposon end compositions and methods for modifying nucleic acids (2019-01-22),

11. 10006007 - RNA preparations comprising purified modified RNA for reprogramming cells (2018-06-26),

12. 9963735 - Selective 5' ligation tagging of RNA (2018-05-08),

13. 9371544 - Compositions and methods for reprogramming eukaryotic cells (2016-06-21),

14. 9371511 - RNA preparations comprising purified modified RNA for reprogramming cells (2016-06-21),

15. 9163213 - RNA preparations comprising purified modified RNA for reprogramming cells (2015-10-20),

Title: Jerome J. Jendrisak: Innovator in Nucleic Acid Technologies

Introduction: Jerome J. Jendrisak, based in Madison, Wisconsin, is a prominent inventor renowned for his extensive contributions to the field of nucleic acid technologies. With a remarkable portfolio of 41 patents, he has significantly advanced methodologies in molecular biology and genetic engineering.

Latest Patents: Among his latest innovations, Jendrisak has developed several noteworthy patents. One of his key inventions is titled "Transposase compositions for reduction of insertion bias." This invention presents methods and compositions for the tagmentation of nucleic acids, enabling the generation of tagged DNA fragments that are representative of the target nucleic acids in a sample. Another pivotal patent is focused on "Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect." This invention encompasses compositions and methods for creating RNA that can induce various biological effects, including reprogramming differentiated cells to pluripotent stem cells.

Career Highlights: Jendrisak has an impressive career trajectory, showcasing his expertise and innovative spirit. He has worked with notable organizations, including Epicentre Technologies Corporation and Cellscript, LLC. His work has often focused on pushing the boundaries of current scientific knowledge and practices within the realm of genetic engineering.

Collaborations: Throughout his career, Jendrisak has collaborated with leading professionals in his field. He has worked closely with esteemed colleagues such as Gary A. Dahl and Anthony Person, contributing to advancements in their shared areas of research and innovation.

Conclusion: Jerome J. Jendrisak stands out as a significant figure in the innovation landscape of nucleic acid technologies. His 41 patents not only highlight his inventiveness but also showcase his dedication to advancing scientific understanding and applications. Jendrisak's contributions continue to have a profound impact, paving the way for future innovations in genetic engineering.

This text is generated by artificial intelligence and may not be accurate.